跳至主要内容
临床试验/NCT04615182
NCT04615182已完成不适用

The Portable Organ Care System (OCS™) Heart For Resuscitation, Preservation and Assessment of Hearts From Donors After Circulatory Death Continued Access Protocol (OCS DCD Heart CAP)

TransMedics49 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2020年11月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
TransMedics
入组人数
90
试验地点
49
主要终点
Patient Survival

研究概览

简要总结

The Portable Organ Care System (OCS™) Heart for Resuscitating, Preserving and Assessing Hearts Donated after Circulatory Death Continued Access Protocol (OCS DCD Heart CAP)

详细描述

To enable continued clinical access to DCD heart transplantation in the U.S. and to continue to collect additional data on the performance of the OCS Heart System to resuscitate, preserve and assess hearts donated after circulatory death for transplantation to increase the pool of donor hearts available for transplantation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • • Primary heart transplant candidates
  • Age ≥ 18 years old
  • Signed: (1) written informed consent document; (2) authorization to use and disclose protected health information; and (3) consent to TransMedics' use of recipients' UNOS/OPTN data and recipients' INTERMACS data.

排除标准

  • Prior solid organ or bone marrow transplant
  • Chronic use of hemodialysis or diagnosis of chronic renal insufficiency
  • Multi-organ transplant.

结局指标

主要结局

Patient Survival

时间窗: 6 months post-transplant

Patient survival at 6 months post-transplant.

次要结局

  • Utilization Rate(24 hours post transplant)

研究者

发起方
TransMedics
申办方类型
Industry
责任方
Sponsor

研究点 (49)

Loading locations...

相似试验

Donor After Circulatory Death Heart CAP Trial | 临床试验